1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Zakova, L. Veverka, V. Jiracek, J. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 90.00 90.00 90.00 1.000 1.000 1.000 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C6 H10 N3 O2 1 156.162 D-HISTIDINE D-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking US J.Biol.Chem. JBCHA3 0071 0021-9258 288 10230 10240 10.1074/jbc.M112.448050 23447530 Structural integrity of the B24 site in human insulin is important for hormone functionality. 2013 2383.698 Insulin A chain 1 syn polymer 3424.926 Insulin B chain F24(D-HIS) 1 syn polymer no no GIVEQCCTSICSLYQLENYCN GIVEQCCTSICSLYQLENYCN A polypeptide(L) no yes FVNQHLCGSHLVEALYLVCGERG(DHI)FYTPKT FVNQHLCGSHLVEALYLVCGERGHFYTPKT B polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n repository Initial release Database references 1 0 2013-03-06 1 1 2013-06-05 BMRB Y RCSB 2012-12-29 REL REL REL 9606 human Homo sapiens sample 9606 human Homo sapiens sample structures with the least restraint violations 100 30 2D 1H-1H TOCSY 2D 1H-1H NOESY 2D DQF-COSY 0.250 mM 0.250 mM 25 mM [U-2H] 0.025 8.0 ambient 298 K simulated annealing 1 closest to the average 0.250 mM chain_A, 0.250 mM chain_B, 25 mM [U-2H] TRIS, 95% H2O/5% D2O CASE, DARDEN, CHEATHAM, III, SIMMERLING, WANG, DUKE, LUO, KOLLMAN refinement AMBER 600 Bruker Avance GLY 1 n 1 GLY 1 A ILE 2 n 2 ILE 2 A VAL 3 n 3 VAL 3 A GLU 4 n 4 GLU 4 A GLN 5 n 5 GLN 5 A CYS 6 n 6 CYS 6 A CYS 7 n 7 CYS 7 A THR 8 n 8 THR 8 A SER 9 n 9 SER 9 A ILE 10 n 10 ILE 10 A CYS 11 n 11 CYS 11 A SER 12 n 12 SER 12 A LEU 13 n 13 LEU 13 A TYR 14 n 14 TYR 14 A GLN 15 n 15 GLN 15 A LEU 16 n 16 LEU 16 A GLU 17 n 17 GLU 17 A ASN 18 n 18 ASN 18 A TYR 19 n 19 TYR 19 A CYS 20 n 20 CYS 20 A ASN 21 n 21 ASN 21 A PHE 1 n 1 PHE 1 B VAL 2 n 2 VAL 2 B ASN 3 n 3 ASN 3 B GLN 4 n 4 GLN 4 B HIS 5 n 5 HIS 5 B LEU 6 n 6 LEU 6 B CYS 7 n 7 CYS 7 B GLY 8 n 8 GLY 8 B SER 9 n 9 SER 9 B HIS 10 n 10 HIS 10 B LEU 11 n 11 LEU 11 B VAL 12 n 12 VAL 12 B GLU 13 n 13 GLU 13 B ALA 14 n 14 ALA 14 B LEU 15 n 15 LEU 15 B TYR 16 n 16 TYR 16 B LEU 17 n 17 LEU 17 B VAL 18 n 18 VAL 18 B CYS 19 n 19 CYS 19 B GLY 20 n 20 GLY 20 B GLU 21 n 21 GLU 21 B ARG 22 n 22 ARG 22 B GLY 23 n 23 GLY 23 B DHI 24 n 24 DHI 24 B PHE 25 n 25 PHE 25 B TYR 26 n 26 TYR 26 B THR 27 n 27 THR 27 B PRO 28 n 28 PRO 28 B LYS 29 n 29 LYS 29 B THR 30 n 30 THR 30 B author_defined_assembly 2 dimeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 10 B B DHI PHE 24 25 144.91 19 B B HIS LEU 5 6 -149.68 27 A A THR SER 8 9 -148.37 29 B B ARG GLY 22 23 147.98 30 B B ARG GLY 22 23 147.36 1 A TYR 19 0.103 SIDE CHAIN 3 7.43 1.20 111.50 118.93 A A A CB CA C CYS CYS CYS 6 6 6 N 4 3.29 0.50 120.30 123.59 B B B NE CZ NH1 ARG ARG ARG 22 22 22 N 16 4.36 0.50 120.30 124.66 B B B NE CZ NH1 ARG ARG ARG 22 22 22 N 1 A GLN 5 57.60 -12.45 1 A CYS 6 56.49 -108.40 1 A CYS 7 55.14 18.26 1 A THR 8 -90.90 -61.70 1 B VAL 2 -133.76 -45.17 1 B CYS 7 64.13 138.41 1 B SER 9 -122.68 -168.05 1 B HIS 10 61.43 -28.64 1 B DHI 24 145.77 -53.50 1 B PHE 25 52.05 -161.90 2 A CYS 7 52.80 -70.92 3 A CYS 6 -80.40 45.11 3 A THR 8 65.31 -50.20 3 B HIS 5 65.74 162.15 4 A CYS 7 65.72 153.85 4 B GLN 4 64.04 156.10 4 B SER 9 61.48 -25.49 4 B DHI 24 79.26 -40.87 4 B TYR 26 54.48 103.79 5 A GLN 5 -78.13 44.48 5 A ILE 10 47.37 94.16 5 B VAL 2 54.62 -54.85 5 B LEU 6 -79.46 46.94 5 B TYR 26 55.22 98.72 6 A GLN 5 -142.15 54.43 6 A CYS 6 55.63 19.70 6 B ASN 3 55.39 -146.64 6 B CYS 7 -147.05 -98.35 6 B HIS 10 60.37 -27.92 6 B GLU 21 58.79 171.72 7 B GLN 4 61.14 174.30 8 B ARG 22 -89.82 33.27 9 A CYS 7 56.03 148.24 9 A SER 9 -103.58 -149.69 9 A SER 12 59.64 167.82 9 B DHI 24 -60.67 -142.35 11 A VAL 3 67.29 -25.02 11 A GLN 5 59.53 -52.95 11 A CYS 7 -167.50 -40.54 11 A LEU 13 62.92 -42.37 12 A THR 8 64.22 -35.65 12 B GLN 4 -69.74 -179.63 12 B CYS 7 -22.74 -45.73 13 A CYS 6 -86.65 42.20 13 A THR 8 60.45 -47.08 13 B VAL 2 64.06 -47.68 13 B CYS 19 -141.74 -32.26 13 B LYS 29 64.99 136.98 14 A CYS 11 61.25 146.74 14 B VAL 2 55.34 -19.96 14 B SER 9 -151.02 13.71 15 A VAL 3 55.58 16.82 15 A SER 12 -78.95 37.22 15 A LEU 13 64.13 -50.56 15 B HIS 10 64.56 -32.63 15 B THR 27 58.00 78.51 16 A GLN 5 61.94 -17.24 16 B ASN 3 -83.25 42.33 16 B SER 9 64.32 -1.98 16 B PHE 25 50.94 -142.32 17 A GLU 4 -80.41 44.91 17 A GLN 5 -129.60 -81.18 17 B PHE 25 -145.56 -45.15 18 A ILE 2 42.98 -149.37 18 A CYS 7 -136.22 -36.14 18 B LEU 6 -107.60 -62.05 18 B CYS 7 62.26 -129.31 18 B HIS 10 62.34 -34.16 18 B TYR 26 -139.54 -63.05 18 B THR 27 50.30 125.57 19 A CYS 6 -69.26 95.31 19 B HIS 5 -149.50 19.46 19 B LEU 6 46.77 -133.10 19 B CYS 7 55.12 -177.12 19 B THR 27 -115.64 78.33 20 B VAL 2 -148.67 -26.12 20 B HIS 10 63.42 -28.87 20 B CYS 19 -91.67 53.61 20 B PHE 25 63.06 -41.03 20 B TYR 26 64.55 -50.14 20 B LYS 29 60.18 175.17 21 A ILE 2 60.75 169.34 21 A CYS 20 -145.96 -40.94 21 B VAL 2 53.61 -44.18 21 B DHI 24 -57.55 150.34 21 B PHE 25 51.23 -105.00 21 B TYR 26 62.59 -50.00 22 A THR 8 54.15 17.91 22 B LEU 6 59.39 -34.90 22 B CYS 19 -128.83 -165.88 23 A GLN 5 49.39 26.72 23 A THR 8 55.51 -34.84 23 B PHE 25 57.95 153.65 24 B VAL 2 52.33 -7.43 24 B GLN 4 -78.96 -152.57 24 B DHI 24 154.21 -11.18 24 B PHE 25 64.38 154.94 25 A VAL 3 -137.28 -30.90 25 A CYS 6 56.50 -80.72 25 A CYS 7 37.51 -76.30 25 B VAL 2 -136.87 -45.12 25 B PHE 25 62.83 -50.88 25 B TYR 26 47.97 82.40 25 B THR 27 -116.30 78.82 26 A VAL 3 -153.22 35.82 26 A GLN 5 68.05 149.19 26 A CYS 7 44.38 -88.67 26 B ASN 3 -152.01 50.18 26 B CYS 7 -88.56 -151.76 26 B SER 9 59.35 162.94 26 B HIS 10 63.02 -38.01 26 B VAL 18 -126.36 -55.65 26 B GLU 21 -130.03 -108.63 27 A CYS 6 -79.96 41.01 27 A SER 9 56.58 153.77 27 A CYS 11 62.01 160.43 27 B SER 9 61.83 -39.89 27 B THR 27 60.46 69.78 28 A GLN 5 57.94 176.36 28 A THR 8 56.23 -43.83 28 B LEU 6 -107.53 78.37 28 B HIS 10 60.20 -22.50 29 A CYS 6 -28.82 110.86 29 A THR 8 57.02 -42.46 29 B VAL 2 64.90 -35.39 29 B GLU 21 -146.28 49.16 29 B ARG 22 61.81 -16.43 30 A CYS 6 -59.04 -73.18 30 A CYS 7 40.59 -91.31 30 B CYS 19 -97.59 30.21 30 B GLU 21 -135.10 -35.23 30 B ARG 22 -163.10 -47.08 30 B THR 27 26.31 66.24 Insulin A chain, Insulin B chain closest to the average, model1 Structure of [D-HisB24] insulin analogue at pH 8.0 1 N N 2 N N A SER 12 A SER 12 HELX_P A ASN 21 A ASN 21 1 1 10 B HIS 10 B HIS 10 HELX_P B CYS 19 B CYS 19 1 2 10 disulf 2.036 A CYS 6 A SG CYS 6 1_555 A CYS 11 A SG CYS 11 1_555 disulf 2.035 A CYS 7 A SG CYS 7 1_555 B CYS 7 B SG CYS 7 1_555 disulf 2.033 A CYS 20 A SG CYS 20 1_555 B CYS 19 B SG CYS 19 1_555 covale 1.337 B GLY 23 B C GLY 23 1_555 B DHI 24 B N DHI 24 1_555 covale 1.343 B DHI 24 B C DHI 24 1_555 B PHE 25 B N PHE 25 1_555 HORMONE insulin, HORMONE B GLN 4 B GLN 4 1 B HIS 5 B HIS 5 -13.30 B CYS 7 B CYS 7 1 B GLY 8 B GLY 8 -6.73 A GLN 5 A GLN 5 2 A CYS 6 A CYS 6 -9.48 B PHE 1 B PHE 1 2 B VAL 2 B VAL 2 -0.15 B PRO 28 B PRO 28 2 B LYS 29 B LYS 29 0.01 A CYS 7 A CYS 7 4 A THR 8 A THR 8 -9.73 A THR 8 A THR 8 4 A SER 9 A SER 9 -1.01 A THR 8 A THR 8 5 A SER 9 A SER 9 -1.48 A GLY 1 A GLY 1 6 A ILE 2 A ILE 2 1.50 B PHE 1 B PHE 1 6 B VAL 2 B VAL 2 -6.20 B GLN 4 B GLN 4 6 B HIS 5 B HIS 5 10.27 B VAL 2 B VAL 2 7 B ASN 3 B ASN 3 -13.00 B GLU 21 B GLU 21 7 B ARG 22 B ARG 22 -3.34 B ARG 22 B ARG 22 7 B GLY 23 B GLY 23 -1.86 B GLY 8 B GLY 8 8 B SER 9 B SER 9 -5.59 B PRO 28 B PRO 28 8 B LYS 29 B LYS 29 -10.37 A CYS 7 A CYS 7 9 A THR 8 A THR 8 -6.65 A THR 8 A THR 8 9 A SER 9 A SER 9 2.48 B GLU 21 B GLU 21 9 B ARG 22 B ARG 22 -6.74 B DHI 24 B DHI 24 9 B PHE 25 B PHE 25 -6.07 B GLY 23 B GLY 23 10 B DHI 24 B DHI 24 0.23 B TYR 26 B TYR 26 11 B THR 27 B THR 27 1.71 A GLY 1 A GLY 1 12 A ILE 2 A ILE 2 4.74 B ASN 3 B ASN 3 12 B GLN 4 B GLN 4 -0.13 B GLY 20 B GLY 20 12 B GLU 21 B GLU 21 1.04 B PRO 28 B PRO 28 12 B LYS 29 B LYS 29 -12.85 A CYS 6 A CYS 6 14 A CYS 7 A CYS 7 -7.66 B GLY 20 B GLY 20 14 B GLU 21 B GLU 21 1.46 B PRO 28 B PRO 28 14 B LYS 29 B LYS 29 3.18 A GLY 1 A GLY 1 15 A ILE 2 A ILE 2 1.50 B CYS 19 B CYS 19 15 B GLY 20 B GLY 20 9.34 A CYS 6 A CYS 6 16 A CYS 7 A CYS 7 -0.26 B PHE 25 B PHE 25 17 B TYR 26 B TYR 26 -12.67 A VAL 3 A VAL 3 19 A GLU 4 A GLU 4 -6.04 B ASN 3 B ASN 3 19 B GLN 4 B GLN 4 -1.47 B GLN 4 B GLN 4 19 B HIS 5 B HIS 5 -0.98 A GLY 1 A GLY 1 22 A ILE 2 A ILE 2 -0.78 B CYS 7 B CYS 7 22 B GLY 8 B GLY 8 -7.37 B ASN 3 B ASN 3 24 B GLN 4 B GLN 4 -8.42 B GLY 23 B GLY 23 24 B DHI 24 B DHI 24 -2.46 B GLN 4 B GLN 4 25 B HIS 5 B HIS 5 8.65 B GLY 20 B GLY 20 25 B GLU 21 B GLU 21 5.57 B GLY 20 B GLY 20 27 B GLU 21 B GLU 21 6.62 B VAL 2 B VAL 2 28 B ASN 3 B ASN 3 -5.77 A GLN 5 A GLN 5 29 A CYS 6 A CYS 6 5.36 B CYS 19 B CYS 19 29 B GLY 20 B GLY 20 -0.63 INS_HUMAN UNP 1 90 P01308 GIVEQCCTSICSLYQLENYCN INS_HUMAN UNP 2 25 P01308 FVNQHLCGSHLVEALYLVCGERGFFYTPKT 90 110 2M2P 1 21 P01308 A 1 1 21 25 54 2M2P 1 30 P01308 B 2 1 30 2 PHE ENGINEERED MUTATION DHI 24 2M2P B P01308 UNP 48 24 BINDING SITE FOR RESIDUE DHI B 24 Software 4 B TYR 16 B TYR 16 4 1_555 B CYS 19 B CYS 19 4 1_555 B GLY 23 B GLY 23 4 1_555 B PHE 25 B PHE 25 4 1_555 1 P 1